InvestorsHub Logo
Followers 105
Posts 2892
Boards Moderated 0
Alias Born 09/16/2011

Re: None

Tuesday, 10/21/2014 8:51:32 PM

Tuesday, October 21, 2014 8:51:32 PM

Post# of 263718
In recent days, some have been somewhat critical of Robert Calkin for splitting his focus between his duties as CEO of Green Cures (GRCU) and his role as CEO of the Cannabis Career Institute.

What I think needs to be emphasized here is that every single thing Robert is able to accomplish in the way of advancement of the acceptance of mj/mmj/cannabis/hemp will have a direct and positive impact on GRCU.

But there is another more subtle (but equally impactful) benefit that GRCU shareholders get as a result of Robert Calkin also serving as CEO of the Cannabis Career Institute.

Many of us are well aware of the OTC CEOs that syphon money, on a regular basis, from the OTC company in which they lead. Many of those CEOs treat the authorized corporate stock as a personal piggy back from which to draw a seemingly endless supply of funds. It is very clear that this is not the case here. And the fact that Robert Calkin is hard working and enterprising enough to have another source of income, insures that there is no need for him to become that kind of CEO. And I think that is the primary explanation for why he was able to accept the modest 4 million GRCU shares provided annually in his employment agreement.

As always, simply my opinion.

GRCU